Skip to content

Drug interactions

Cabergoline + Efavirenz

Severity: Moderate

Cabergoline and Efavirenz: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Efavirenz may alter cabergoline exposure through effects on CYP3A4, and higher levels could cause hypotension or ergot-related vasospasm. The interaction is predicted rather than well documented.

What this interaction means in plain words

Cabergoline and Efavirenz can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Cabergoline belongs to Endocrine; Efavirenz belongs to Anti Virals.

Evidence level: Low

Why it happens

Efavirenz modulates CYP3A4 activity, which may change cabergoline metabolism; the direction and extent are uncertain.

What to do

Monitor for ergot-related adverse effects and for changes in prolactin control. Adjust the cabergoline dose according to response.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Cabergoline and Efavirenz, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Cabergoline with Efavirenz?

MediHelp rates the interaction as moderate. Cabergoline and Efavirenz can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Efavirenz may alter cabergoline exposure through effects on CYP3A4, and higher levels could cause hypotension or ergot-related vasospasm. The interaction is predicted rather than well documented.

How serious is the interaction between Cabergoline and Efavirenz?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for ergot-related adverse effects and for changes in prolactin control. Adjust the cabergoline dose according to response.

What other medicines interact with Efavirenz?

MediHelp also lists interactions of Efavirenz with, for example, Cobimetinib, Dienogest / estradiol valerate, Dihydroergotamine intranasal. The full list is on the Efavirenz page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in